Skip to main content
Clinical Trials/IRCT20210403050815N1
IRCT20210403050815N1
Recruiting
Phase 3

Evaluation of the ?effect of Topical Intranasal Tranexamic Acid for Stopping Nose Bleeding in Patients with Epistaxis in the ENT Emergency Department

Shiraz University of Medical Sciences0 sites240 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiraz University of Medical Sciences
Enrollment
240
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged 18 or over
  • Presenting to the Ear, Nose, and Throat emergency department (ED) with spontaneous, atraumatic anterior epistaxis, unresolved with simple first aid

Exclusion Criteria

  • Hemodynamically unstable
  • Known allergy to tranexamic acid
  • Lacking capacity or unwilling to give consent
  • Known nasopharyngeal, nasal cavity or paranasal malignancy
  • Already undergone prehospital nasal packing
  • Epistaxis caused by trauma (excluding simple nose picking)
  • Any Known bleeding disorders
  • Any recent use of anticoagulation drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials